Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Titel:
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Auteur:
Tendler, Salomon Dunphy, Mark P Agee, Matthew O'Donoghue, Joseph Aly, Rania G Choudhury, Noura J Kesner, Adam Kirov, Assen Mauguen, Audrey Baine, Marina K Schoder, Heiko Weber, Wolfgang A Rekhtman, Natasha Lyashchenko, Serge K Bodei, Lisa Morris, Michael J Lewis, Jason S Rudin, Charles M Poirier, John T